Trade BioNTech ^BNTX

BMO Capital Cuts PT on BioNTech SE (BNTX) to $128 From $143 - Here's Why

BioNTech (NASDAQ:BNTX) Given New $130.00 Price Target at HC Wainwright

3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Sees Significant Decrease in Short Interest - Daily Political

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Short Interest Down 20.7% in March

BioNTech (NasdaqGS:BNTX) Valuation Check After New Lung Cancer Data Highlights Oncology Pipeline Progress

Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial

BioNTech (NASDAQ:BNTX) Upgraded to Strong-Buy at Truist Financial

BioNTech SE Sponsored ADR $BNTX Shares Bought by SG Americas Securities LLC

BioNTech Lung Cancer Data Broadens Oncology Story Beyond Infectious Diseases

BioNTech's (BNTX) Buy Rating Reaffirmed at Jefferies Financial Group

In the clinic for March 25, 2026 | BioWorld

Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial

DualityBio (9606.HK) Announces 2025 Annual Results

BioNTech Cofounder Exits Put Leadership Transition And Pipeline Execution In Focus

BioNTech's (BNTX) Buy Rating Reiterated at Deutsche Bank Aktiengesellschaft - Stock Observer

Research Analysts' Recent Ratings Changes for BioNTech (BNTX) - Stock Observer

Hudson Bay Capital Management LP Acquires 55,004 Shares of BioNTech SE Sponsored ADR $BNTX - Markets Daily

Groupama Asset Managment Cuts Position in BioNTech SE Sponsored ADR $BNTX - Daily Political

BioNTech (NASDAQ:BNTX) Earns "Buy" Rating from Deutsche Bank Aktiengesellschaft

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Rating of "Moderate Buy" from Brokerages

BioNTech (NASDAQ:BNTX) Cut to Sell at Wall Street Zen

Wall Street Zen Downgrades BioNTech (NASDAQ:BNTX) to Sell - Daily Political

BioNTech (NASDAQ:BNTX) Downgraded by Wall Street Zen to "Sell" - Markets Daily

Why BioNTech (BNTX) Is Down 10.2% After Founders Announce Spinout And mRNA Asset Transfer

BioNTech's (BNTX) "Buy" Rating Reiterated at The Goldman Sachs Group - Markets Daily

BioNTech SE Sponsored ADR $BNTX Shares Acquired by Dodge & Cox

TD Cowen Cuts BioNTech (NASDAQ:BNTX) Price Target to $94.00 - Stock Observer

Assessing BioNTech (NasdaqGS:BNTX) Valuation After Founders' Planned Exit And Weakening COVID-19 Revenues

Best Biotech Stocks To Research - March 13th - Markets Daily

Jefferies Financial Group Cuts BioNTech (NASDAQ:BNTX) Price Target to $138.00 - Stock Observer

Is It Time To Reconsider BioNTech (BNTX) After Its Recent Share Price Weakness?

BioNTech (NASDAQ:BNTX) Given Buy Rating at Canaccord Genuity Group - Markets Daily

Is BioNTech (BNTX) Starting To Look Attractive After Recent Share Price Weakness

BioNTech (NASDAQ:BNTX) Given New $94.00 Price Target at TD Cowen - Daily Political

BioNTech's (BNTX) "Buy" Rating Reiterated at Canaccord Genuity Group

BioNTech's Promising Oncology Pipeline Is Now in Late-Stage Development | Morningstar

BioNTech (NASDAQ:BNTX) Given New $130.00 Price Target at Citigroup

BioNTech (NASDAQ:BNTX) Sees Large Volume Increase - Here's What Happened

TD Cowen Has Lowered Expectations for BioNTech (NASDAQ:BNTX) Stock Price

BMO Capital Markets Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock Price

BioNTech (NASDAQ:BNTX) Receives "Buy" Rating from The Goldman Sachs Group

US Stock Market Today: S&P 500 Futures Edge Lower As Inflation Jitters Linger

BioNTech SE Sponsored ADR $BNTX Shares Sold by Capital International Inc. CA

BioNTech founders to quit roles to start new venture - Türkiye News

BioNTech Founders to Leave Company by 2026 for New mRNA Venture, ETPharma

Clinical development of cancer vaccines

Founders of German vaccine maker BioNTech to step down, lead new firm

Health Care Down Amid Mixed Earnings - Health Care Roundup | Morningstar

BioNTech Stock Plunges as Founders Leave. Should You Buy the Dip in BNTX Here?

BioNTech (NASDAQ:BNTX) Given New $138.00 Price Target at Jefferies Financial Group

BioNTech founders to leave, launch new company

BioNTech SE (BNTX) Q4 2025 Earnings Call Highlights: Strategic Advances Amidst Revenue Challenges

Stocks making the biggest moves midday: RIVN, HIMS, KSS, CASY, VRTX

BioNTech founders step down to start new venture - Yahoo News UK

Why BioNTech Stock Is Getting Crushed Today

Analysts' Updated EPS Estimates for March 10th (ADM, ARGX, BNTX, CASY, DAVE, DOM, GFM, KSS, MKS, SBRE) - Daily Political

BioNTech Q4 Earnings Call Highlights | MarketBeat

BioNTech Q4 Earnings Call Highlights - Markets Daily

BioNTech Stock Falls 21% Over Turning To Loss In Q4, Weak FY26 Outlook, Co-Founders Plan To Exit

BioNTech Tumbles as Founding Duo Plan to Leave to Start New Firm

BioNTech (BNTX) Stock Plunges 17% Following Founder Exodus and Disappointing Earnings

BioNTech Slips To Loss In Q4, Warns On Weak FY26 Revenues; Shares Plunge In Pre-market

Scientists behind COVID-19 vaccine will depart BioNTech | Morningstar

BioNTech (NASDAQ:BNTX) Announces Earnings Results, Beats Estimates By $0.18 EPS

Dow Jones Top Company Headlines at 7 AM ET: Bill Ackman's Pershing Square USA Files for IPO | BioNTech ... | Morningstar

BioNTech Repositions From COVID-19 Cash Flows To Oncology-Focused Future

Is BioNTech's (BNTX) Oncology Pivot Rewriting Its Post‑COVID Investment Story?

Assessing BioNTech (BNTX) Valuation After Oncology Pivot And Bristol Myers BNT327 Deal

Is BioNTech SE (BNTX) A Good Stock To Buy Now?

Moderna Settles Patent Dispute for Up to $2.25 Billion, Shares Surge, ETPharma

US Stocks: Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhang - The Economic Times

Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang

Is BioNTech (BNTX) Offering Value After Recent Share Price Weakness?

Moderna agrees to pay up to $2.87 billion to settle Covid-19 vaccine patent dispute

TD Asset Management Inc Trims Holdings in BioNTech SE Sponsored ADR $BNTX - Stock Observer

BioNTech (BNTX) Expected to Announce Quarterly Earnings on Monday

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Meta Platforms: Navigating Legal Headwinds and AI Opportunities for Investors

US Stocks Poised for Potential Rebound Amidst Easing Geopolitical Tensions and Shifting Investor Positioning

UAE as Global Gold Powerhouse: Analyzing the 2026 Resilience of Dubai’s Gold Trading Ecosystem

Investing in US Stocks from South Africa: Step-by-Step Guide for ZA Investors

How to Invest in Stocks for Beginners (Europe): Opportunities, Risks and Smart Strategies in 2026

Forex Market Today: BRICS+ Currency Dynamics, USD/AED Stability, Key Currency Trading Opportunities

European Stocks Overview: European Shares Slide as Middle East Conflict Fuels Inflation Fears

Lucid Group (LCID) stock dropped 98%: Should you buy the deep? Is LCID stock a good investment?

Ukraine Forges New Alliances in the Middle East, Leveraging Defense Expertise

US Reinforces Middle East Presence Amid Escalating Tensions with Iran

Fed Policy Pivot: Inflation Risks Hint at Potential Rate Hikes, Shifting Market Expectations

TotalEnergies Dominates Middle East Oil Market in March, Securing Record Profits

Navigating Economic Crosscurrents: Market Outlook Amidst Geopolitical Turmoil

Ukraine Hints at Reduced Strikes on Russian Energy Amid Partner Pressure, Secures Middle East Support

Hormuz Strait Tensions Escalate: US Threatens 'Total Destruction' Amidst Regional Proxy Engagements

Nasdaq Accelerates New Listings into Key Indices Amidst Mega IPO Preparations